Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.
2.

Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.

Ludovini V, Pistola L, Gregorc V, Floriani I, Rulli E, Di Carlo L, Semeraro A, Daddi G, Darwish S, Stocchi L, Tofanetti FR, Bellezza G, Sidoni A, Tognellini R, Crinò L, Tonato M.

Tumori. 2008 May-Jun;94(3):398-405.

3.
4.

A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER-positive breast cancer.

Ali HR, Dawson SJ, Blows FM, Provenzano E, Leung S, Nielsen T, Pharoah PD, Caldas C.

J Pathol. 2012 Jan;226(1):97-107. doi: 10.1002/path.2976. Epub 2011 Sep 26.

PMID:
21953021
5.
6.

The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.

Ishida H, Irie K, Itoh T, Furukawa T, Tokunaga O.

Cancer. 1997 Sep 15;80(6):1034-45.

PMID:
9305703
7.

The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.

Nakopoulou L, Vourlakou C, Zervas A, Tzonou A, Gakiopoulou H, Dimopoulos MA.

Hum Pathol. 1998 Feb;29(2):146-54.

PMID:
9490274
8.

Bcl-2 immunostaining: a way to finding unresponsive postmenopausal N+ breast cancer patients.

Jalava PJ, Collan YU, Kuopio T, Juntti-Patinen L, Kronqvist P.

Anticancer Res. 2000 Mar-Apr;20(2B):1213-9.

PMID:
10810424
9.

p53 over-expression identifies a subset of nodal peripheral T-cell lymphomas with a distinctive biological profile and poor clinical outcome.

Pescarmona E, Pignoloni P, Puopolo M, Martelli M, Addesso M, Guglielmi C, Baroni CD.

J Pathol. 2001 Oct;195(3):361-6.

PMID:
11673835
10.

[Multivariate analysis of recurrence and progression in stage T1 transitional-cell carcinoma of the bladder. Prognostic value of p53 and Ki67].

Rodríguez Alonso A, Pita Fernández S, González-Carreró J, Nogueira March JL.

Actas Urol Esp. 2003 Feb;27(2):132-41. Review. Spanish.

PMID:
12731328
11.

MIB1 proliferation index in breast infiltrating carcinoma: comparison with other proliferative markers and association with new biological prognostic factors.

González-Vela MC, Garijo MF, Fernández F, Val-Bernal JF.

Histol Histopathol. 2001 Apr;16(2):399-406.

PMID:
11332695
12.
13.

Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis.

Bhatavdekar JM, Patel DD, Shah NG, Vora HH, Suthar TP, Chikhlikar PR, Ghosh N, Trivedi TI.

Ann Surg Oncol. 2000 May;7(4):305-11.

PMID:
10819372
14.

Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis.

Li SS, Xue WC, Khoo US, Ngan HY, Chan KY, Tam IY, Chiu PM, Ip PP, Tam KF, Cheung AN.

Histopathology. 2005 Mar;46(3):307-13.

PMID:
15720416
15.

Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer.

Yamashita H, Nishio M, Toyama T, Sugiura H, Zhang Z, Kobayashi S, Iwase H.

Breast Cancer Res. 2004;6(1):R24-30. Epub 2003 Nov 7.

16.

The role of p53 and Ki67 in Paget's disease of the vulva and the breast.

Ellis PE, Fong LF, Rolfe KJ, Crow JC, Reid WM, Davidson T, MacLean AB, Perrett CW.

Gynecol Oncol. 2002 Aug;86(2):150-6.

PMID:
12144821
17.

Prognostic value of proliferative activity and nuclear morphometry for progression in TaT1 urothelial cell carcinomas of the urinary bladder.

Bol MG, Baak JP, Rep S, Marx WL, Kruse AJ, Bos SD, Kisman O, Voorhorst FJ.

Urology. 2002 Dec;60(6):1124-30.

PMID:
12475695
18.
19.

Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival.

Pich A, Margaria E, Chiusa L.

J Clin Oncol. 2000 Aug;18(16):2948-56.

PMID:
10944127
20.

Apoptosis in breast carcinoma.

González-Cámpora R, Galera Ruiz MR, Vázquez Ramírez F, Ríos Martín JJ, Fernández Santos JM, Ramos Martos MM, Gómez Pascual A.

Pathol Res Pract. 2000;196(3):167-74.

PMID:
10729921
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk